Middle East & Africa Heparin Market Size & Outlook
Middle East & Africa heparin market, 2018-2030 (US$M)
Related Markets
MEA heparin market highlights
- The MEA heparin market generated a revenue of USD 192.5 million in 2023.
- The market is expected to grow at a CAGR of 3.6% from 2024 to 2030.
- In terms of segment, porcine was the largest revenue generating source in 2023.
- Bovine is the most lucrative source segment registering the fastest growth during the forecast period.
- Country-wise, South Africa is expected to register the highest CAGR from 2024 to 2030.
MEA data book summary
| Market revenue in 2023 | USD 192.5 million |
| Market revenue in 2030 | USD 246.0 million |
| Growth rate | 3.6% (CAGR from 2023 to 2030) |
| Largest segment | Porcine |
| Fastest growing segment | Bovine |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Porcine, Bovine |
| Key market players worldwide | Pfizer Inc, Sanofi SA, Aspen Pharmacare Holdings Ltd, Fresenius SE & Co KGaA, Novartis AG ADR, GSK PLC ADR, Dr. Reddy’s Laboratories, LEO Pharma, B. Braun Medical |
Other key industry trends
- In terms of revenue, MEA region accounted for 2.6% of the global heparin market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 2,436.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Heparin Market Scope
Heparin Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa heparin market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to heparin market will help companies and investors design strategic landscapes.
Porcine was the largest segment with a revenue share of 87.64% in 2023. Horizon Databook has segmented the Middle East & Africa heparin market based on porcine, bovine covering the revenue growth of each sub-segment from 2018 to 2030.
Saudi Arabia held the largest share of the MEA market in 2019, owing to its economic development and improving healthcare infrastructure. The viability of this region as a major investor has led to growth in number of pharmaceutical manufacturers in South Africa, the UAE, and Saudi Arabia.
Growing incidence of thalassemia in the Mediterranean region, MEA, or Asia has resulted in high demand for blood components. This factor, coupled with an increase in number of blood transfusions, development of good infrastructure, increase in healthcare expenditure, and growing interest of biopharmaceutical companies in targeting more patients are expected to propel the market over the forecast period.
The MEA’s prevalence of stroke ranges from 508 to 777 per 100,000 population each year. Kuwait leads the prevalence of obesity in the Middle East with 40% in adults and ranks 12th in the world for obesity rate.
Reasons to subscribe to Middle East & Africa heparin market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa heparin market databook
-
Our clientele includes a mix of heparin market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa heparin market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa heparin market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA heparin market size, by country, 2018-2030 (US$M)
Middle East & Africa Heparin Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
